首页 | 本学科首页   官方微博 | 高级检索  
     

Antisense therapeutics: is it as simple as complementary base recognition?
引用本文:Agrawal S,Kandimalla ER. Antisense therapeutics: is it as simple as complementary base recognition?[J]. Molecular medicine today, 2000, 6(2): 72-81. DOI: 10.1016/S1357-4310(99)01638-X
作者姓名:Agrawal S  Kandimalla ER
摘    要:


Antisense therapeutics: is it as simple as complementary base recognition?
Agrawal S,Kandimalla E R. Antisense therapeutics: is it as simple as complementary base recognition?[J]. Molecular medicine today, 2000, 6(2): 72-81. DOI: 10.1016/S1357-4310(99)01638-X
Authors:Agrawal S  Kandimalla E R
Affiliation:Hybridon, 155 Fortune Boulevard, Milford, MA 01757, USA. sagrawal@hybridon.com
Abstract:Antisense oligonucleotides provide a simple and efficient approach for developing target-selective drugs because they can modulate gene expression sequence-specifically. Antisense oligonucleotides have also become efficient molecular biological tools to investigate the function of any protein in the cell. As the application of antisense oligonucleotides has expanded, multiple mechanisms of oligonucleotides have been characterized that impede their routine use. Here, we discuss different mechanisms of action of oligonucleotides and the possible ways of minimizing non-antisense-related [corrected] effects to improve their specificity.
Keywords:
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号